Overview

Mono Efficacy of Capecitabine (MoniCa)

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Study done in patients with metastatic breast cancer in order to determine the efficacy of capecitabine
Phase:
Phase 2
Details
Lead Sponsor:
German Breast Group
Collaborator:
Hoffmann-La Roche
Treatments:
Capecitabine